Cargando…

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection

To determine the effect renin-angiotensin system blockers on the outcome in patients with hypertension and concurrent COVID-19 infection, we searched PubMed, the Cochrane Library, and Google Scholar for relevant articles. Twelve studies with a total of 16,101 patients met the inclusion criteria. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salah, Husam M., Calcaterra, Guisseppe, Mehta, Jawahar L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404086/ https://www.ncbi.nlm.nih.gov/pubmed/32748634 http://dx.doi.org/10.1177/1074248420947628

Ejemplares similares

The Effect of Anticoagulation Use on Mortality in COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19
por: Salah, Husam M., et al.
Publicado: (2021)

Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19
por: Salah, Husam M., et al.
Publicado: (2021)

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients
por: Chen, Chen, et al.
Publicado: (2020)

Renin–angiotensin system inhibitors and mortality in patients with COVID-19
por: Rossi, Luca, et al.
Publicado: (2020)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Renin-angiotensin system at the interface of COVID-19 infection
por: Gul, Rukhsana, et al.
Publicado: (2021)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
por: Kang, Si-Hyuck, et al.
Publicado: (2021)

Smoking Doubles the Mortality Risk in COVID-19: A Meta-Analysis of Recent Reports and Potential Mechanisms
por: Salah, Husam M, et al.
Publicado: (2020)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
por: Angeli, Fabio, et al.
Publicado: (2022)

COVID-19 Vaccine and Myocarditis
por: Salah, Husam M., et al.
Publicado: (2021)

The systemic renin-angiotensin system in COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients
por: Gori, Mauro, et al.
Publicado: (2022)

Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension
por: Kuzeytemiz, Mustafa, et al.
Publicado: (2022)

Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19
por: Silva, Mauro G., et al.
Publicado: (2022)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Role of the central renin-angiotensin system in hypertension (Review)
por: Su, Chuanxin, et al.
Publicado: (2021)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics
por: Gismondi, Ronaldo Altenburg, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4ukj88d0u8ntjji26rbb2fl34h